Tag:

heart defibrillators

Latest Headlines

Latest Headlines

MIT, UMass look to protect implantable devices from attack

Millions of patients around the world have implantable medical devices. And because these devices--including pacemakers and defibrillators--have wireless connections, they are vulnerable to attack.

Boston Sci introduces smallest, thinnest high-energy CRT-Ds and ICDs

Boston Scientific announced Friday the launch and first implants of its Energen and Punctua cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators in Europe and

FDA could toughen regs for defibrillators

The FDA is mulling stricter approval regulations for external defibrillators following dozens of recalls involving hundreds of thousands of the devices. In documents posted late last week, the agency

FDA looks to work with industry to solve defibrillator problems

Over the past five years, the FDA's Center for Devices and Radiological Health has received more than 28,000 medical device reports associated with the failures of external defibrillators. In

FDA gives Boston Sci good news on CRT-Ds

The FDA has allowed an expanded indication for Boston Scientific's cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS CRT-D. According to the company, this decision makes

Boston Scientific enrolls first patient in heart failure trial

Natick, MA-based Boston Scientific ( NYSE: BSX ) has enrolled its first patient in its MultiSENSE clinical trial, which will study the early alerts of heart failure. The trial combines the company's

Judge delays decision on Guidant-Justice settlement after plaintiffs cry foul

A federal judge Monday delayed a decision on whether to accept a $296 million plea agreement between the Justice Department and Guidant, a unit of Boston Scientific, that had been charged with

Report: FDA won't speed Boston Scientific review

FDA officials said Thursday they won't expedite the review of manufacturing changes Boston Scientific needs to make to help it resume selling its implantable heart defibrillators. Boston Scientific